Alivus Life Sciences Ltd. Investor Presentation

Alivus Life Sciences Ltd. Investor Presentation: Get insights into company performance, financials, capex plans and more

Quarter

Conference/Earnings Calls Alerts

Alivus Life Sciences Ltd.

21 Jul 2023

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investor Presentation Q1 FY24

pdf

Alivus Life Sciences Ltd.

27 Apr 2023

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf

Alivus Life Sciences Ltd.

27 Jan 2023

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf

Alivus Life Sciences Ltd.

17 Nov 2022

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Investors Presentation - Glenmark Life Sciences Limited Investor Day 2022

pdf

Alivus Life Sciences Ltd.

17 Nov 2022

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Further to our communication dated November 11, 2022, attached is a copy of the presentation to be made at Glenmark Life Sciences Limited - Investor Day 2022 which is scheduled today at 15:45 IST in Mumbai. Kindly take the same on record and acknowledge receipt.

pdf

Alivus Life Sciences Ltd.

21 Oct 2022

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf

Alivus Life Sciences Ltd.

04 Aug 2022

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf

Alivus Life Sciences Ltd.

20 Apr 2022

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf

Alivus Life Sciences Ltd.

08 Feb 2022

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf

Alivus Life Sciences Ltd.

10 Nov 2021

888.65

0.82%

Investor Presentation

Glenmark Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing the investor presentation.

pdf